Loic Feuvret

Bron, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 104 publications

Prognostic factors in adult patients with medulloblastoma.

Prognostic factors in adult patients with medulloblastoma.

Journal: Neuro-oncology practice

Published: March 09, 2026

Dynamic susceptibility contrast MRI-derived oxygen metabolism and perfusion metrics for distinguishing radiation necrosis from tumor progression in irradiated brain metastases.

Dynamic susceptibility contrast MRI-derived oxygen metabolism and perfusion metrics for distinguishing radiation necrosis from tumor progression in irradiated brain metastases.

Journal: Diagnostic and interventional imaging

Published: September 10, 2025

Diagnostic value of centrally restricted diffusion in differentiating radiation necrosis from tumor progression in brain metastases: A single-center observational study.

Diagnostic value of centrally restricted diffusion in differentiating radiation necrosis from tumor progression in brain metastases: A single-center observational study.

Journal: Journal of neuroradiology = Journal de neuroradiologie

Published: July 30, 2025

Aggressive pituitary tumors and pituitary carcinomas: Definition, management, and overview for clinical practice.

Aggressive pituitary tumors and pituitary carcinomas: Definition, management, and overview for clinical practice.

Journal: Neuro-oncology advances

Published: July 28, 2025

Multimodal Imaging to Improve Patient Selection and Optimize Treatment Planning and Delivery for Patients Undergoing Reirradiation: A Scoping Review.

Multimodal Imaging to Improve Patient Selection and Optimize Treatment Planning and Delivery for Patients Undergoing Reirradiation: A Scoping Review.

Journal: Current oncology reports

Published: July 17, 2025

Radiotherapy guidelines for gliomas: 2025 update.

Radiotherapy guidelines for gliomas: 2025 update.

Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

Published: June 30, 2025

Real-world survival and prognostic factors in WHO 2021 classified gliomas treated with chemo-radiotherapy.

Real-world survival and prognostic factors in WHO 2021 classified gliomas treated with chemo-radiotherapy.

Journal: Scientific reports

Published: June 29, 2025

Predominantly cystic craniopharyngiomas: Current management approaches, outcomes and limitations.

Predominantly cystic craniopharyngiomas: Current management approaches, outcomes and limitations.

Journal: Best practice & research. Clinical endocrinology & metabolism

Published: February 08, 2025

Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma.

Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: October 02, 2024

Olaparib, Temozolomide, and Concomitant Radiotherapy for Partially Resected or Biopsy-Only Glioblastoma First-Line Treatment: Results from the OLA-TMZ-RTE-01 Phase I Study.

Olaparib, Temozolomide, and Concomitant Radiotherapy for Partially Resected or Biopsy-Only Glioblastoma First-Line Treatment: Results from the OLA-TMZ-RTE-01 Phase I Study.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: September 10, 2024

Diagnosis and management of children and adult craniopharyngiomas: A French Endocrine Society/French Society for Paediatric Endocrinology & Diabetes Consensus Statement.

Diagnosis and management of children and adult craniopharyngiomas: A French Endocrine Society/French Society for Paediatric Endocrinology & Diabetes Consensus Statement.

Journal: Annales d'endocrinologie

Published: June 16, 2024

Proton therapy versus conventional radiotherapy for the treatment of cavernous sinus benign meningioma, a randomized controlled phase III study protocol (COG-PROTON-01).

Proton therapy versus conventional radiotherapy for the treatment of cavernous sinus benign meningioma, a randomized controlled phase III study protocol (COG-PROTON-01).

Journal: BMC cancer

Published: June 02, 2024

Showing 1-12 of 104

Last Updated: 09/26/2026